Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biology of Young Lung Cancer Study: The YOUNG LUNG Study

NCT05265429 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.

NCT NCT05265429
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05265429 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biology of Young Lung Cancer Study: The YOUNG LUNG Study
Lead sponsor
Dana-Farber Cancer Institute
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2023
Completion date
August 1, 2027
Enrollment
500 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

non small cell lung cancer, nut carcinoma, small cell lung carcinoma